Enclomiphene and Finasteride Interaction: Avoid | Peptide Database

Join others researching Abaloparatide — share findings, ask questions, and learn from real experiences Abaloparatide is an FDA-approved anabolic bone-building agent and synthetic analog of parathyroid hormone-related protein (PTHrP). It selectively activates the PTH1 receptor to stimulate new bone formation while minimizing bone resorption. In the phase III ACTIVE trial, abaloparatide showed superior BMD increases at the hip compared to teriparatide, with substantial fracture risk reduction. It was approved in the US in 2017 and EU in 2022 for postmenopausal women and men with osteoporosis at high fracture risk. Abaloparatide works through selective activation of the parathyroid hormone 1 receptor (PTH1R), a G protein-coupled receptor expressed on osteoblasts and osteocytes. It preferentially binds to the RG (relaxed, G-protein-coupled) conformational state of PTH1R, which elicits a transient downstream cyclic AMP signaling response favoring anabolic bone formation over resorption. This selective binding pattern produces more bone-building activity with less hypercalcemic effect compared to native PTH. The result is increased cortical and trabecular bone volume, density, and improved microarchitecture.

Treatment of overt and subclinical hypothyroidism, either as monotherapy or in combination with levothyroxine (T4). Particularly useful in patients who report persistent symptoms despite normalized TSH on T4 monotherapy, suggesting poor peripheral conversion. Emergency treatment of severe hypothyroidism presenting as myxedema coma. Intravenous T3 is preferred due to its rapid onset of action compared to T4. Supplementation in individuals with documented poor conversion of T4 to T3 due to deiodinase polymorphisms (DIO2 gene variants), chronic caloric restriction, illness, or elevated reverse T3 levels. Diagnostic use in thyroid suppression tests to differentiate between types of thyroid autonomy. Widely used in bodybuilding and physique sports to accelerate fat loss during caloric deficit. T3 increases basal metabolic rate by 10-15% at moderate doses, promoting faster utilization of stored fat. Most effective when combined with adequate protein intake and resistance training to minimize muscle catabolism. Used by biohackers and longevity-focused individuals to maintain optimal metabolic rate, particularly during extended caloric restriction, reverse dieting, or in the context of metabolic adaptation (adaptive thermogenesis). Standard component of bodybuilding contest prep stacks, typically combined with anabolic steroids (to offset catabolism) and beta-2 agonists for maximal fat mobilization in the final 6-8 weeks before competition.